GWAS |
- Blood protein levels ( 30072576)
- Body mass index (alcohol intake interaction) ( 23192594)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cerebrospinal fluid AB1-42 levels ( 28247064)
- Cortical surface area (min-P) ( 32665545)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (min-P) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- General risk tolerance (MTAG) ( 30643258)
- Number of sexual partners ( 30643258)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Type 2 diabetes nephropathy ( 30566433)
- Urinary metabolite levels in chronic kidney disease ( 31959995)
|
- Adult body size ( 32376654)
- Alzheimer's disease ( 20452100)
- Bitter alcoholic beverage consumption ( 31046077)
- Body size at age 10 ( 32376654)
- Intraocular pressure ( 29785010)
- LDL levels x SSRI levels (escitalopram or citalopram) interaction in schizophrenia or bipolar disorder ( 33824429)
- Metabolite levels (Pyroglutamine) ( 23934736)
- Morning person ( 30696823)
- Multiple sclerosis (age of onset) ( 19010793)
- Night sleep phenotypes ( 27126917)
- Otosclerosis ( 19230858)
- Response to placebo treatment in childhood asthma (FVC change) ( 31557306)
- Schizophrenia ( 18282107)
- Sjögren's syndrome ( 28076899)
- Sucrose liking ( 31005972)
- Type 2 diabetes ( 30054458 30297969)
- Venous thromboembolism adjusted for sickle cell variant rs77121243-T ( 28203683)
|